Host Genetic Susceptibility to Avian Influenza A/H5N1
NCT01074736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2010-11-04
Summary
The identification and characterization of susceptibility loci for H5N1 infection in humans could have profound implications. The detection of host genetic factors may shed light on key pathogenic interactions between H5N1 and human cells, assisting in identifying the viral characteristics determining pandemic potential. In addition, the identification and verification of susceptibility loci would be followed by functional studies which might point the way to new therapeutic and preventive options.
The objective of this study is to investigate if host genetic factors are associated with susceptibility to influenza H5N1 illness
Conditions
- Influenza A Virus/H5N1 Subtype
Sponsors & Collaborators
-
University of Oxford
collaborator OTHER -
Wellcome Trust
collaborator OTHER -
South East Asia Infectious Disease Clinical Research Network
lead NETWORK
Principal Investigators
-
Tawee Chotpitayasunond, Professor · Queen Sirikit National Institute of Child Health, Bangkok, Thailand
-
Herawati Sudoyo, Dr. · Eijkman Institute for Molecular Biology
-
Tran Hien Nguyen, Professor · National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
-
Martin Hibberd, Dr. · Genome Institute of Singapore, Singapore
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-10-31
Countries
- Vietnam
Study Locations
More Related Trials
-
China Case Control Avian Influenza
NCT00428753 ·Status: COMPLETED
-
Safety Study of Avian Flu Vaccine
NCT00408109 ·Status: COMPLETED ·Phase: PHASE1
-
Virus Shedding and Environmental Deposition of a Novel Influenza Virus
NCT01046734 ·Status: COMPLETED
-
Vaccine for Prevention of Bird Flu
NCT00776711 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza
NCT07215871 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
NCT01006798 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
NCT01560793 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults
NCT01250795 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
NCT01443663 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
NCT01086657 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Assays for Detection of Influenza Virus
NCT03924284 ·Status: WITHDRAWN
-
Safety and Immunogenicity of Live Attenuated Influenza H5N2
NCT01841918 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
NCT00489931 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers
NCT01656356 ·Status: COMPLETED ·Phase: PHASE1
-
Study of a Pandemic Influenza Vaccine
NCT00136331 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
NCT00478816 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00462215 ·Status: COMPLETED ·Phase: PHASE3
-
Household Influenza Transmission Study
NCT01251679 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
NCT01658800 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions
NCT02091908 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of Avian Influenza Transmission to Humans in Egypt
NCT01150552 ·Status: COMPLETED
-
Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine
NCT00240903 ·Status: COMPLETED ·Phase: PHASE1